Our CEO and founder, Anna Maxwell has been listed in the top 50 movers and shakers of 2019 by BioBusiness
Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia
C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of Maxwellia, about what makes a successful POM to P change
Maxwellia had the opportunity to put the switch agenda on the radar of Matt Hancock, Secretary of State for Health and Social Care
Maxwellia is mentioned in Forbes for aligning to Global Goal 3 Good Health
Appointments will expedite conversion of prescription medicines to over the counter
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescription-to-OTC reclassification.
Investment will expedite conversion of prescription medicines to over the counter